Case report of a pituitary macroadenoma treated with artemether

Integrative Cancer Therapies

Volumn 5, Issue 4, 2006, Pages 391-394

  Singh, Narendra P ^a   Panwar, Vijay Kumar ^b  

^a University of Washington   (United States)

^b Primary Health Center   (India)

Author keywords

Apoptosis; Artemether; Artemisinin; Cancer; Microadenoma; Pituitary gland

Indexed keywords

ALPHA TOCOPHEROL; ARTEMETHER; ARTEMISIN DERIVATIVE; ASCORBIC ACID;

AGED; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; HEARING DISORDER; HUMAN; HYPOPHYSIS; HYPOPHYSIS ADENOMA; MALE; MOTOR DYSFUNCTION; PITUITARY MACROADENOMA; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; TUMOR DIAGNOSIS; VISUAL DISORDER;

ADENOMA; AGED; ANTINEOPLASTIC AGENTS; ARTEMISININS; HUMANS; MALE; PITUITARY NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33750858216     PISSN: 15347354     EISSN: 1552695X     Source Type: Journal    
DOI: 10.1177/1534735406295311     Document Type: Article

References (25)

1. Kreutzer J, Fahlbusch R. Diagnosis and treatment of pituitary tumors. Curr Opin Neurol. 2004;17:693-703.
2. Johnson MD, Woodburn CJ, Vance ML. Quality of life in patients with a pituitary adenoma. Pituitary. 2003;6:81-87.
3. Seriovilla L, Nunez L, de Campos JM, et al. Multifunctional cells in human pituitary adenomas: implications for paradoxical secretion and tumorigenesis. J Clin Endocrinol Metab. 2004;89:4545-4552.
4. Yildiz F, Zorlu F, Erbas F, Atahan L. Radiotherapy in the management of giant pituitary adenomas. Radiother Oncol. 1999;32:233-237.
5. Park P, Chandler WF, Barkan AL, et al. The role of radiation therapy after surgical resection of nonfunctional pituitary macroadenomas. Neurosurg. 2004;55:100-106.
6. Dekkers OM, Pereira AM, Roelfsema F, et al. Observation alone after transsphenoidal surgery for non-functioning pituitary macroadenoma. J Clin Endocrinol Metab. 2006;91:1796-1801.
7. Sassolas G, Trouillas J, Treluyer C, Perrin G. Management of nonfunctioning pituitary adenomas. Acta Endocrinol. 1993;129(Suppl):21-26.
8. Zhang F, Gosser DK Jr, Meshnick SR. Hemin-catalyzed decomposition of artemisinm (qinghaosu). Biochem Pharmacol. 1992;43:1805-1809.
9. Lai H, Singh NP. Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrin. Cancer Lett. 1995;91:41-46.
10. Singh NP, Lai H. Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells. Life Sci. 2001;70:49-56.
11. Peys E, Vandenkerckhove J, Van Hemel J, Sas B. Intermediate-term toxicity of repeated orally administered doses of the anti-malarial beta-artemether in dogs. Exp Toxicol Pathol. 2006;57:299-304.
12. Utzinger J, Xiao SH, N'Goran EK, Bergquist R, Tanner M. The potential of artemether for the control of schistosomiasis. Int J Parasitol. 2001;31:1549-1562.
13. Utzinger J, N'Goran E, N'Dri A, Lengeler C, Shutma X, Tanner M. Oral artemether for prevention of infection: randomised controlled trial. Lancet. 2000;355:1320-1325.
14. Xiao S, Yang Y, You O, et al. Potential long-term toxicity of repeated orally administered doses of artemether in rats. Am J Trop Med Hyg. 2002;66:30-34.
15. Murray RA, Maheshwari HG, Russell EJ, Bauman G. Pituitary hypoplasia in patients with a mutation in the growth hormone-releasing hormone receptor gene. Am J Neuroradiol. 2000;21:685-689.
16. Moore JC, Lai H, Li JR, McDougall JA, Singh NP, Chou CK. Oral administration of dihydroartemisinin and ferrous sulfate retarded implanted fibrosarcoma growth in the rat. Cancer Lett. 1995;98:83-87.
17. Efferth T, Dunstan H, Sauerbrey A, Miyachi H, Chitambar CR. The anti-malarial artesunate is also active against cancer. Int J Oncol. 2001;18:767-773.
18. Singh NP, Verma KB. Case report of a laryngeal squamous cell carcinoma treated with artesunate. Arch Oncol. 2002;10:279-280.
19. Berger TG, Dieckmann D, Efferth T, et al. Artesunate in the treatment of metastatic uveal melanoma-first experiences. Oncol Rep. 2005;14:1599-1603.
20. Singh NP, Lai H. Artemisinin induces apoptosis in human cancer cells. AntiCancer Res. 2004;24:2277-2280.
21. Ezzat S, Asa SL, Couldwell WT, et al. The prevalence of pituitary adenomas: a systematic review. Cancer. 2004;101:613-619.
22. Feldkamp J, Santen R, Harms E, Aulich A, Modder U, Scherbaum WA. Incidentally discovered pituitary lesions: high frequency of macroadenomas and hormone-secreting adenomas - results of a prospective study. Clin Endocrinol (Oxf). 1999;51:109-113.
23. Arita K, Tominaga A, Sugiyama K, et al. Natural course of incidentally found nonfunctioning pituitary adenoma, with special reference to pituitary apoplexy during follow-up examination. J Neurosurg. 2006;104:884-891.
24. Kabil MS, Ebv JB, Shahinian HK. Fully endoscopic endonasal vs. transseptal transsphenoidal pituitary surgery. Minim Invasive Neurosurg. 2005;48:348-354.
25. Zaugg M, Adaman O, Pescia R, Landolt AM. External irradiation of macroinvasive pituitary adenomas with telecobalt: a retrospective study with long-term follow-up in patients irradiated with doses mostly of between 40-45 Gy. Int J Radiat Oncol Biol Phys. 1995;32:671-680.